BioTechnique®
June 16, 2025
Company Presentation
Contract Manufacturing Organization
153B
BioTechnique® is a full-service CRDMO providing cytotoxic and therapeutic sterile injectable fill-finish services. From investigational/clinical to final marketed product, BioTechnique® can provide fill-finish services to batch sizes both big and small.
Company HQ City:
York
Company HQ State:
Pennsylvania
Company HQ Country:
United States
Year Founded:
2020
Lead Product in Development:
N/A
CEO
John Clapham
Development Phase of Lead Product
Multiple Products in Market
What is your next catalyst (value inflection) update?
N/A
Website
https://biotechnique.com/
Primary Speaker
.jpg)
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}